International Journal of Pharmaceutical Investigation volume 16, issue 3 cover
Search this issue

Cover: International Journal of Pharmaceutical Investigation

International Journal of Pharmaceutical Investigation

Volume 16, Issue 3

2026 · pp. 770–1201 · 34 articles

Volume
16
Issue
3
Published
2026
Pages
770–1201
Articles
34
Sections
3
ISSN
Print - 2230-973X, Online -2230-9713
Journal
IJPI

In this issue

21–34 of 34

Original Article(continued)

  1. Article

    Badupula Sravan Kumar, Roopa Redamala

    pp. 1078–1089 · DOI: 10.5530/ijpi.20260115 · 2026

    Aim To estimate Remogliflozin and Teneligliptin simultaneously in bulk and pharmaceutical dosage forms, including forced degradation studies, a simple, Robust, and Stability-Indicating (RP-H-P-L-C) method has been develo…

  2. Article

    Dasharath Muljibhai Patel, Shipra Vijayesh Pandey

    pp. 1090–1097 · DOI: 10.5530/ijpi.20260127 · 2026

    Objectives India's rapidly growing medical device industry, which is expected to rank among the biggest in the world in the next ten years, is heavily regulated by the Central Drugs Standard Control Organization (CDSCO).…

  3. Article

    Emmanuel Madugula, Niranjan Patra, Tinku Baidya

    pp. 1098–1103 · DOI: 10.5530/ijpi.20260132 · 2026

    Background Isotretinoin, a retinoid derivative of vitamin A, is widely used for the treatment of severe recalcitrant acne, reduces sebum production, suppresses sebaceous gland activity, and exhibits potent anti-inflammat…

  4. Article

    Gangayya Jagadish Wakkundmath, Madiwalayya Shivakantayya Ganachari, Geetanjali Salimath

    pp. 1104–1109 · DOI: 10.5530/ijpi.20260144 · 2026

    Background The presence of community pharmacists in the field is particularly important because they operate on the front line of contact with the population when providing the best health care. Evaluating their Knowledg…

  5. Article

    Harika Gadiparthi, Hema Gayatri Simhadri, Chandrasekhar Chanda

    pp. 1110–1116 · DOI: 10.5530/ijpi.20260156 · 2026

    Objectives Glucose Oxidase (GOx) is a essential enzyme used in several industries, including food, pharmaceuticals, and biotechnology. However, commercial-scale production continues to face challenges due to high process…

  6. Article

    Kurubara Amaresh, Madiwalayya Shivakantayya Ganachari, Revana Siddappa Devarinti

    pp. 1117–1122 · DOI: 10.5530/ijpi.20260171 · 2026

    Background Surplus human biospecimens serve as a valuable resource for advancing scientific discovery, and their ethical management is essential for maintaining integrity in biomedical research. Clinical Trial Sponsors h…

  7. Article

    Vijay Sharma, Maneesh Kumar Singh, Gurvinder Pal Singh, Gyanendra Kumar Sharma, Navneet Verma

    pp. 1123–1134 · DOI: 10.5530/ijpi.20260567 · 2026

    Aim/Background The aim of the present study was to develop and optimize a dosage form of L-arginine as a nanoparticle for prolonged release. The Quality by Design (QbD) approach was employed to develop and optimize the d…

  8. Article

    Sreeraj Kandoth, Narayana Charyulu Rompicherla, Sarath Chandran Chadrashekar Shenoy, Uday Venkat Mateti, Juno Jerold Joel, Sarin Shyamala Mohanan

    pp. 1135–1142 · DOI: 10.5530/ijpi.20260205 · 2026

    Background Topical Corticosteroids (TCs) are widely prescribed for managing dermatological conditions due to their efficacy in reducing inflammation and related symptoms. However, misuse, suboptimal prescribing practices…

  9. Article

    Ghadeer Bukhari

    pp. 1143–1151 · DOI: 10.5530/ijpi.20260265 · 2026

    Background The NS5 protein in Dengue Virus Serotype-1 (DENV-1) is a multifunctional enzyme that is crucial for the virus to reproduce and evade the immune system. One important part of NS5 is the methyltransferase (MTase…

  10. Article

    Rametrika Saha, Veeranagoud Biradar, Spoorti Konkani, Mandati Santhosh Reddy, Bhavana Doshi

    pp. 1152–1157 · DOI: 10.5530/ijpi.20260228 · 2026

    Background Pemphigus vulgaris (PV) is a severe autoimmune blistering disorder traditionally managed with corticosteroids, which are associated with significant adverse effects; as a result, alternative therapies such as …

  11. Article

    Pradeep Kumar, Vaibhav Rastogi

    pp. 1158–1169 · DOI: 10.5530/ijpi.20260288 · 2026

    Background Apixaban is a novel oral anticoagulant widely used in the treatment and prevention of thromboembolic disorders. However, oral administration is associated with delayed onset of action and inaccurate gastrointe…

  12. Article

    Mandati Santhosh Reddy, Madiwalayya Shivakantayya Ganachari

    pp. 1170–1175 · DOI: 10.5530/ijpi.20260262 · 2026

    Background Antiplatelet therapy is central to managing Coronary Artery Disease (CAD), but benefits are offset by Adverse Drug Reactions (ADRs), particularly bleeding. Objectives To compare the causality, severity, and pr…

  13. Article

    Nawal Helmi, Hanadi Mohammed Baeissa, Israa Jameel Hakeem, Dalia Muhammed Alammari

    pp. 1176–1182 · DOI: 10.5530/ijpi.20260009 · 2026

    Background High-touch surfaces in healthcare settings can act as reservoirs for microbial transmission, underscoring the need for durable antimicrobial surface interventions that remain effective under realistic use cond…

Research Article

  1. Article

    Susmita Mandal, Deep Shende

    pp. 984–989 · DOI: 10.5530/ijpi.20260045 · 2026

    Background The increasing risk of antibiotic resistance is a major worldwide health concern, with especially dire repercussions for children. The purpose of this study is to investigate the causes, effects, and preventat…